Actionnariat et activité des initiés pour Tarsus Pharmaceuticals, Inc. (TARS): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $77.64 |
| Capitalisation | $3.3B |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-09-04 | Azamian Bobak R. | S-Sale | 7,100 | $641K |
| 2026-09-04 | Azamian Bobak R. | S-Sale | 2,900 | $265K |
| 2026-09-04 | Lin Elizabeth Yeu | S-Sale | 5,387 | $458K |
| 2026-09-04 | Lin Elizabeth Yeu | S-Sale | 1,590 | $135K |
| 2026-09-04 | Lin Elizabeth Yeu | S-Sale | 5,386 | $485K |
| 2026-09-04 | Lin Elizabeth Yeu | S-Sale | 1,590 | $143K |
| 2026-09-04 | Neervannan Seshadri | S-Sale | 4,564 | $388K |
| 2026-09-02 | Azamian Bobak R. | S-Sale | 10,000 | $801K |
| 2026-09-01 | Lin Elizabeth Yeu | S-Sale | 4,601 | $340K |
| 2026-09-02 | Lin Elizabeth Yeu | S-Sale | 5,387 | $431K |
Bilan (10 ans)
| Année | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Trésorerie | $2.4M | $58.0M | $168.1M | $171.3M | $71.7M | $224.9M | $94.8M | $183.6M |
| Placements à Court Terme | 0 | 0 | 0 | $483000 | $145.4M | $2.5M | $196.6M | $233.6M |
| Créances | $4000 | $36000 | $20000 | $92000 | $3.6M | $17.7M | $48.1M | $87.1M |
| Stocks | 0 | 0 | 0 | 0 | 0 | $3.1M | $2.6M | $4.4M |
| Actifs Courants | $2.4M | $58.0M | $170.7M | $176.0M | $225.4M | $256.1M | $356.7M | $522.8M |
| Immobilisations Corporelles | $6000 | $280000 | $1.2M | $1.8M | $1.5M | $3.3M | $2.9M | $21.7M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | $3.9M | $8.3M | $7.4M |
| Actifs Totaux | $2.4M | $58.3M | $172.0M | $178.9M | $227.9M | $265.5M | $377.0M | $562.2M |
| Dettes Fournisseurs | $175000 | $456000 | $2.2M | $2.9M | $5.5M | $17.8M | $27.7M | $16.4M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $179000 | $819000 | $5.4M | $11.5M | $15.4M | $36.9M | $80.6M | $135.7M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | $19.4M | $29.8M | $71.8M | $83.0M |
| Passifs Totaux | $3.7M | $64.3M | $6.0M | $12.2M | $35.0M | $68.5M | $152.5M | $218.7M |
| Réserves | -$1.4M | -$6.0M | -$32.8M | -$46.7M | -$108.8M | -$244.7M | -$360.2M | -$426.6M |
| Capitaux Propres | -$1.4M | -$6.0M | $166.0M | $166.7M | $192.9M | $197.0M | $224.5M | $343.4M |
| Dette Totale | 0 | $164000 | $831000 | $1.9M | $20.2M | $30.2M | $72.5M | $93.6M |
| Dette Nette | -$2.4M | -$57.8M | -$167.3M | -$169.9M | -$196.8M | -$197.2M | -$218.9M | -$323.6M |
| Fonds de Roulement | $2.2M | $57.2M | $165.3M | $164.5M | $209.9M | $219.2M | $276.1M | $387.1M |
Santé financière
| Dette / Capitaux propres | 0.27 |
| Ratio de liquidité | 3.85 |
| Piotroski F-Score | 5 |
| Altman Z-Score | 9.54 |
Rentabilité
| Rentabilité des capitaux propres | -13.53% |
| Rentabilité du capital investi | -11.15% |
| Rentabilité des actifs | -7.60% |
| Marge brute | 93.20% |
| Marge opérationnelle | -15.72% |
| Marge nette | -14.72% |
Entreprises liées: AAPG · ADPT · ARQT · CELC · CGON · IRON · LEGN
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de TARS: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions